C. Escuriola Ettingshausen

发表

A review of immune tolerance induction with Haemate® P in haemophilia A

W. Kreuz, C. Escuriola Ettingshausen, C. Ettingshausen, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII‐treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study

R. Schutgens, C. Escuriola Ettingshausen, A. Borel Derlon, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

The importance of inhibitor eradication in clinically complicated hemophilia A patients

J. Oldenburg, E. Santagostino, G. Young, 2018, Expert review of hematology.

Symptomatic Onset of Severe Hemophilia A in Childhood is Dependent on the Presence of Prothrombotic Risk Factors

R. Junker, K. Kurnik, W. Kreuz, 2001, Thrombosis and Haemostasis.

Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A

A. Iorio, M. Marcucci, E. Santagostino, 2015, Thrombosis and Haemostasis.

Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement

A. Iorio, E. Iserman, J. Oldenburg, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding – Successful thrombolysis under heparin therapy

W. Kreuz, C. Escuriola Ettingshausen, I. M. Saguer, 1999, European Journal of Pediatrics.

Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study

V. Jiménez‐Yuste, A. Pavlova, V. Vdovin, 2022, TH open : companion journal to thrombosis and haemostasis.

Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE)

R. Sidonio, C. Escuriola Ettingshausen, 2021, Therapeutic advances in hematology.

Inhibitors: Diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment in China

Wenman Wu, S. Meeks, C. Escuriola Ettingshausen, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Achievements, challenges and unmet needs for haemophilia patients with inhibitors

D. Scott, David Steven Scott, S. Lacroix-Desmazes, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Prevention of joint damage in hemophilic children with early prophylaxis

W. Kreuz, C. Escuriola Ettingshausen, M. Funk, 1999, Der Orthopäde.

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

J. Oldenburg, V. Jiménez‐Yuste, A. Pavlova, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Common themes and challenges in hemophilia care: a multinational perspective

K. Batt, R. Wu, M. Mancuso, 2018, Hematology.

Favorable pharmacokinetics in hemophilia B for nonacog beta pegol versus recombinant factor IX‐Fc fusion protein: A randomized trial

R. Klamroth, M. Simpson, C. Escuriola Ettingshausen, 2019, Research and practice in thrombosis and haemostasis.

Population Pharmacokinetic Modeling Of On-Demand And Surgical Use Of Nonacog Beta Pegol (N9-GP) And rFIXFc Based Upon The paradigm 7 Comparative Pharmacokinetic Study

D. Cooper, R. Klamroth, M. Simpson, 2019, Journal of blood medicine.

[Prevention of joint damage in hemophilic children with early prophylaxis].

W. Kreuz, C. Escuriola Ettingshausen, M. Funk, 1999, Der Orthopade.

Inhibitor treatment by rituximabin congenital haemophilia A

W. Kreuz, C. Escuriola Ettingshausen, R. Linde, 2009, Hämostaseologie.

Inhibitors: A Need for Eradication?

V. Jiménez‐Yuste, E. Santagostino, M. Carcao, 2019, Acta Haematologica.

First experience of a hemophilia monitoring platform: florio HAEMO

A. Batorova, C. Escuriola Ettingshausen, P. Laguna, 2022, Research and practice in thrombosis and haemostasis.

Delayed diagnosis of hereditary angioedema: Thirty-nine years of inadequate treatment.

C. Escuriola Ettingshausen, I. Martínez-Saguer, 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Successful management of hereditary angioedema during pregnancy in a patient with heterozygous MTHFR mutation.

C. Escuriola Ettingshausen, I. Martinez Saguer, 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.